DE3787241D1
(en )
1993-10-07
Monoclonal antibodies against human tumor necrosis factor (TNF) and their use.
DE68918497D1
(en )
1994-11-03
Monoclonal mouse antibodies against HIV-IP24 and their use in diagnostics.
DE3484520D1
(en )
1991-06-06
MONOCLONAL ANTIBODIES AGAINST HUMAN COLON CANCER AND METHOD.
DE69319662D1
(en )
1998-08-20
Monoclonal antibodies to GP130 protein
FI925631L
(en )
1992-12-11
MONOCLONAL ANTIBODY
DE3854502D1
(en )
1995-10-26
AGAINST HIV-ANTIGENT SPECIFIC MONOCLONAL ANTIBODIES.
DE3788148D1
(en )
1993-12-23
Monoclonal antibodies and their use.
DE3767400D1
(en )
1991-02-21
BIOCID COMPOSITIONS AND THEIR USE.
FR2631239B1
(en )
1994-05-27
HUMAN MONOCLONAL ANTIBODIES AND HYBRIDOMA PRODUCING THE SAME
DE3688864D1
(en )
1993-09-16
L-PHENYLALANINEDEHYDROGENASE AND THEIR USE.
DE3689948D1
(en )
1994-08-11
MONOCLONAL ANTIBODIES AND TEST PROCEDURE.
FI940811A7
(en )
1994-02-21
Human monoclonal anti-Rhesus(D) antibodies and cell lines producing them
DE3766441D1
(en )
1991-01-10
ANILINOTRIAZINE AND THEIR USE.
NO170691C
(en )
1992-11-18
ONCOPHETAL SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF
DE3587714D1
(en )
1994-02-17
Human alpha 2-plasmin specific monoclonal antibody.
DE3888604D1
(en )
1994-04-28
Monoclonal antibodies against antithrombin binding substance and its uses.
DE3580482D1
(en )
1990-12-13
MONOCLONAL ANTIBODIES AND IMMUNIZATION THEREFOR.
DE69024871D1
(en )
1996-02-29
Monoclonal antibody to human BCDF and immunoassay method using it
DE58907320D1
(en )
1994-05-05
Bituminous mass and its use.
EP0229107A4
(en )
1987-11-09
HUMAN MONOCLONAL ANTIBODIES AGAINST PSEUDOMONAS-AERUGINOSA-EXOTOXIN.
ATE93895T1
(en )
1993-09-15
MONOCLONAL ANTIBODIES ANTI-HUMAN TUMONIC CROSS FACTOR (TNF) AND THEIR USE.
DE3673794D1
(en )
1990-10-04
MONOCLONAL ANTIBODIES AGAINST GAMMA INTERFERON, THEIR PRODUCTION AND USE.
FI945485L
(en )
1994-11-22
Monoclonal antibodies and their use
DE3868608D1
(en )
1992-04-02
ORGANOZINN-ALKOXYCARBONYLPHENYLMERCAPTIDE AND THEIR USE.
DE3584280D1
(en )
1991-11-07
MONOCLONAL ANTIBODY AGAINST HUMAN CANCER.